Document Detail


Development of the human coagulation system in the healthy premature infant.
MedLine Citation:
PMID:  3179444     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was designed to determine the postnatal development of the human coagulation system in the healthy premature infant. Consecutive mothers of healthy premature infants born at either St Joseph's Hospital or McMaster University Medical Centre in Hamilton were asked for consent. One hundred thirty-seven premature infants (30 to 36 weeks of gestational age) entered the study. The premature infants did not have any major health problems and did not require ventilation or supplemental oxygen. Demographic information and a 20-mL blood sample were obtained in the postnatal period on days 1, 5, 30, 90, and 180. Between 40 and 96 premature infants were studied on each day for each of the following tests: prothrombin time, activated partial thromboplastin time, thrombin clotting time, plasminogen; 13 factor assays [fibrinogen, II, V, VII, VIII, IX, X, XI, XII, XIII, high-mol-wt kininogen (HMWK), prekallikrein (PK), von Willebrand factor (vWF)] and eight inhibitors [antithrombin III (AT-III), heparin cofactor II, alpha 2-antiplasmin, alpha 2-macroglobulin, alpha 1-antitrypsin, C1 esterase inhibitor, protein C (PC), and protein S (PS)]. A combination of biologic and immunologic assays were used. Between 30 to 36 weeks there was a minimal effect of gestational age for levels of AT-III, PC, and factors II and X only; therefore, the entire data set was used to generate reference ranges for these components of the coagulation system for premature infants. Next, the results for the premature infants were compared with those of a previously published study in 118 fullterm infants and with those for adults. An effect of gestational age was shown for plasminogen, fibrinogen, factors II, V, VIII, IX, XI, XII, HMWK, and all eight inhibitors. In general, the postnatal maturation towards adult levels was accelerated in premature infants as compared with the fullterm infants. By 6 months of age, most components of the coagulation system in premature infants had achieved near adult values.
Authors:
M Andrew; B Paes; R Milner; M Johnston; L Mitchell; D M Tollefsen; V Castle; P Powers
Related Documents :
73554 - Haemostatic disorders and respiratory distress in the newborn.
5909694 - Haemangiomata of the placenta.
15726674 - Maternal ratings of temperamental characteristics of healthy premature infants are indi...
17438834 - Paleopathological findings of dry skulls with plagiocephaly.
17318354 - Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants wit...
8897044 - Spondyloepimetaphyseal dysplasia with joint laxity (semdjl) in three neonates.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Blood     Volume:  72     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  1988 Nov 
Date Detail:
Created Date:  1988-12-08     Completed Date:  1988-12-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1651-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Blood Coagulation*
Blood Coagulation Factors / analysis
Humans
Infant, Newborn
Infant, Premature / blood*
Grant Support
ID/Acronym/Agency:
HL-27589/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  B protein of factor XIII: differentiation between free B and complexed B.
Next Document:  Comparison of transferrin receptor-mediated endocytosis and drug-induced endocytosis in human neonat...